JLens 500 Jewish Advocacy U.S. ETF
TOV
12 hedge funds and large institutions have $32.4M invested in JLens 500 Jewish Advocacy U.S. ETF in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
363% more capital invested
Capital invested by funds: $7M → $32.4M (+$25.4M)
200% more funds holding
Funds holding: 4 → 12 (+8)
13.77% more ownership
Funds ownership: 5.88% → 19.64% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cambridge Associates
Boston,
Massachusetts
|
+$15.3M |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$5.57M |
| 3 |
Corient Private Wealth
Miami,
Florida
|
+$960K |
| 4 |
MASUI
MIRAE ASSET SECURITIES (USA) INC.
New York
|
+$820K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$48.6K |
Top Sellers
TOV Hedge Fund Activity: Q2 2025 in Review
12 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in JLens 500 Jewish Advocacy U.S. ETF (TOV) for Q2 2025, worth a combined $32.4M — up 363% from $7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TOV positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cambridge Associates, opening a new position worth an estimated $15.3M.
- 12 institutional investors held JLens 500 Jewish Advocacy U.S. ETF (TOV) as of Q2 2025, up from 4 in Q1 2025.
- Funds reported $32.4M of JLens 500 Jewish Advocacy U.S. ETF stock for Q2 2025, up 363% quarter-over-quarter.
- 9 funds opened new JLens 500 Jewish Advocacy U.S. ETF positions in Q2 2025 and 0 closed out, a net change of +9 holders.
- The largest JLens 500 Jewish Advocacy U.S. ETF buyer in Q2 2025 was Cambridge Associates, an estimated $15.3M added.
Based on aggregated 13F filings for Q2 2025.